Application Information

This drug has been submitted to the FDA under the reference 021332/001.

Names and composition

"SYMLIN" is the commercial name of a drug composed of PRAMLINTIDE ACETATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021332/001 SYMLIN PRAMLINTIDE ACETATE INJECTABLE/SUBCUTANEOUS EQ 3MG BASE per 5ML (EQ 600MCG BASE per ML)
021332/002 SYMLIN PRAMLINTIDE ACETATE INJECTABLE/SUBCUTANEOUS EQ 1.5MG BASE per 1.5ML (EQ 1MG BASE per ML)
021332/003 SYMLIN PRAMLINTIDE ACETATE INJECTABLE/SUBCUTANEOUS EQ 2.7MG BASE per 2.7ML (EQ 1MG BASE per ML)

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021332/001 SYMLIN PRAMLINTIDE ACETATE INJECTABLE/SUBCUTANEOUS EQ 3MG BASE per 5ML (EQ 600MCG BASE per ML)
021332/002 SYMLIN PRAMLINTIDE ACETATE INJECTABLE/SUBCUTANEOUS EQ 1.5MG BASE per 1.5ML (EQ 1MG BASE per ML)
021332/003 SYMLIN PRAMLINTIDE ACETATE INJECTABLE/SUBCUTANEOUS EQ 2.7MG BASE per 2.7ML (EQ 1MG BASE per ML)

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved